Do we really need new anti-infective drugs?

Current Opinion in Pharmacology

Volumn 3, Issue 5, 2003, Pages 459-463

  Rice, Louis B ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; IMIPENEM; LINEZOLID; M PROTEIN; MACROLIDE; MEROPENEM; METICILLIN; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; POLYMYXIN; POLYMYXIN B; POLYMYXIN C; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIAL STRAIN; COMMUNICABLE DISEASE; DRUG CLASSIFICATION; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

EID: 0141535272     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2003.05.001     Document Type: Review

References (30)

1. Manikal V.M. Landman D. Saurina G. Oydna E. Lal H. Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage Clin Infect Dis 31 2000 101-106
2. Landman D. Quale J.M. Mayorga D. Adedeji A. Vangala K. Ravishankar J. Flores C. Brooks S. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned Arch Intern Med 162 2002 1515-1520
3. Vergis E.N. Hayden M.K. Chow J.W. Snydman D.R. Zervos M.J. Linden P.K. Wagener M.M. Schmitt B. Muder R.R. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study Ann Intern Med 135 2001 484-492
4. Pai M.P. Rodvold K.A. Schreckenberger P.C. Gonzales R.D. Petrolatti J.M. Quinn J.P. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium Clin Infect Dis 35 2002 1269-1272
5. Marshall S.H. Donskey C.J. Hutton-Thomas R. Salata R.A. Rice L.B. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis Antimicrob Agents Chemother 46 2002 3334-3336
6. Kohler T. Michea-Hamzehpour M. Henze U. Gotoh N. Curty L.K. Pechere J.C. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa Mol Microbiol 23 1997 345-354
7. Li X.Z. Barre N. Poole K. Influence of the MexA-MexB-oprM multidrug efflux system on expression of the MexC-MexD-oprJ and MexE-MexF-oprN multidrug efflux systems in Pseudomonas aeruginosa J Antimicrob Chemother 46 2000 885-893
8. Mao W. Warren M.S. Lee A. Mistry A. Lomovskaya O. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa Antimicrob Agents Chemother 45 2001 2001-2007
9. Masuda N. Sakagawa E. Ohya S. Gotoh N. Tsujimoto H. Nishino T. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa Antimicrob Agents Chemother 44 2000 3322-3327
10. Stover C.K. Pham X.Q. Erwin A.L. Mizoguchi S.D. Warrener P. Hickey M.J. Brinkman F.S. Hufnagle W.O. Kowalik D.J. Lagrou M. et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen Nature 406 2000 959-964
11. Pai H. Kim J. Lee J.H. Choe K.W. Gotoh N. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates Antimicrob Agents Chemother 45 2001 480-484
12. Dubois V. Arpin C. Melon M. Melon B. Andre C. Frigo C. Quentin C. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance J Clin Microbiol 39 2001 2072-2078
13. Gerson S.L. Kaplan S.L. Bruss J.B. Le V. Arellano F.M. Hafkin B. Kuter D.J. Hematologic effects of linezolid: summary of clinical experience Antimicrob Agents Chemother 46 2002 2723-2726
14. Tsiodras S. Pittet D. Carmeli Y. Eliopoulos G. Boucher H. Harbarth S. Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals Scand J Infect Dis 32 2000 651-656
15. Paulsen I.T. Banerjei L. Myers G.S. Nelson K.E. Seshadri R. Read T.D. Fouts D.E. Eisen J.A. Gill S.R. Heidelberg J.F. et al. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis Science 299 2003 2071-2074
16. Moore M.R. Perdreau-Remington F. Chambers H.F. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis Antimicrob Agents Chemother 47 2003 1262-1266
17. Chang S. Sievert D.M. Hageman J.C. Boulton M.L. Tenover F.C. Downes F.P. Shah S. Rudrik J.T. Pupp G.R. Brown W.J. et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N Engl J Med 348 2003 1342-1347
18. Blumberg H.M. Rimland D. Carroll D.J. Terry P. Wachsmuth I.K. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus J Infect Dis 163 1991 1279-1285
19. Martin J.M. Green M. Barbadora K.A. Wald E.R. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh N Engl J Med 346 2002 1200-1206
20. Bisno A.L. Brito M.O. Collins C.M. Molecular basis of group A streptococcal virulence Lancet Infect Dis 3 2003 191-200
21. Biswas B. Adhya S. Washart P. Paul B. Trostel A.N. Powell B. Carlton R. Merril C.R. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium Infect Immun 70 2002 204-210
22. Pittet D. Mourouga P. Perneger T.V. Compliance with handwashing in a teaching hospital. Infection Control Program Ann Intern Med 130 1999 126-130
23. Rosdahl V.T. Knudsen A.M. The decline of methicillin resistance among Danish Staphylococcus aureus strains Infect Control Hosp Epidemiol 12 1991 83-88
24. Roberts RB, de Lancastre A, Eisner W, Severina EP, Shopsin B, Kreiswirth BN, Tomasz A: the MRSACollaborative Study Group: Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. J Infect Dis 1998, 178:164-171.
25. Morris J.G. Shay D.K. Hebden J.N. McCarter R.J. Jr. Perdue B.E. Jarvis W. Johnson J.A. Dowling T.C. Polish L.B. Schwalbe R.S. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a University medical center Ann Intern Med 123 1995 250-259
26. Peña C. Pujol M. Ardanuy C. Ricart A. Pallares R. Linares J. Ariza J. Gudiol F. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases Antimicrob Agents Chemother 42 1998 53-58
27. Rahal J.J. Urban C. Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites Clin Infect Dis 34 2002 499-503
28. Rice L.B. Eckstein E.C. DeVente J. Shlaes D.M. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center Clin Infect Dis 23 1996 118-124
29. Bonten M.J.M. Slaughter S. Ambergen A.W. Hayden M.K. van Voorhis J. Nathan C. Weinstein R.A. The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci Arch Intern Med 158 1998 1127-1132
30. Donskey C.J. Chowdhry T.K. Hecker M.T. Hoyen C.K. Hanrahan J.A. Hujer A.M. Hutton-Thomas R.A. Whalen C.C. Bonomo R.A. Rice L.B. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients N Engl J Med 343 2000 1925-1932